These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 168379)
41. Immunologic dysfunction during viral oncogenesis. II. Inhibition of cellular immunity to viral antigens by malignant rabbit fibroma virus. Skaletsky E; Sharp PA; Sell S; Strayer DS Cell Immunol; 1984 Jun; 86(1):64-74. PubMed ID: 6327086 [TBL] [Abstract][Full Text] [Related]
42. Differences between extracellular and intracellular forms of poxvirus and their implications. Boulter EA; Appleyard G Prog Med Virol; 1973; 16():86-108. PubMed ID: 4356899 [No Abstract] [Full Text] [Related]
43. Serological relationships between poxviruses of different genera: studies with vaccinia virus and myxoma virus. Alcock SR J Comp Pathol; 1981 Oct; 91(4):493-502. PubMed ID: 6172453 [No Abstract] [Full Text] [Related]
44. Coevolution of host and virus: cellular localization of virus in myxoma virus infection of resistant and susceptible European rabbits. Best SM; Collins SV; Kerr PJ Virology; 2000 Nov; 277(1):76-91. PubMed ID: 11062038 [TBL] [Abstract][Full Text] [Related]
45. Studies on antigenicity, toxicity & pharmacologic activities of soluble antigen of vaccinia virus. Singh LM Indian J Exp Biol; 1972 Sep; 10(5):344-6. PubMed ID: 4121207 [No Abstract] [Full Text] [Related]
46. An in vitro measure of cellular immunity to fibroma virus. Tompkins WA; Adams C; Rawls WE J Immunol; 1970 Feb; 104(2):502-10. PubMed ID: 4904883 [No Abstract] [Full Text] [Related]
47. Expression of the myxoma virus tumor necrosis factor receptor homologue and M11L genes is required to prevent virus-induced apoptosis in infected rabbit T lymphocytes. Macen JL; Graham KA; Lee SF; Schreiber M; Boshkov LK; McFadden G Virology; 1996 Apr; 218(1):232-7. PubMed ID: 8615027 [TBL] [Abstract][Full Text] [Related]
48. Tumorigenic poxviruses: fine analysis of the recombination junctions in malignant rabbit fibroma virus, a recombinant between Shope fibroma virus and myxoma virus. Upton C; Macen JL; Maranchuk RA; DeLange AM; McFadden G Virology; 1988 Sep; 166(1):229-39. PubMed ID: 2842947 [TBL] [Abstract][Full Text] [Related]
49. Replication of vesicular stomatitis virus facilitated in nonpermissive cells by early functions of Shope fibroma virus. Crouch NA Proc Soc Exp Biol Med; 1978 Feb; 157(2):225-30. PubMed ID: 202973 [No Abstract] [Full Text] [Related]
50. Shope fibroma virus. I. Biological and molecular properties of a cytocidal and a noncytocidal strain. Pogo BG; Freimuth P; Stein A J Virol; 1982 Jan; 41(1):97-103. PubMed ID: 6283131 [TBL] [Abstract][Full Text] [Related]
51. [Mechanism of the immunological adjuvant effect of vaccinia-virus]. Bandlow G; Fischer W; Thomssen R Arch Gesamte Virusforsch; 1972; 38(2):192-204. PubMed ID: 4198012 [No Abstract] [Full Text] [Related]
52. Tumorigenic poxviruses: genomic organization of malignant rabbit virus, a recombinant between Shope fibroma virus and myxoma virus. Block W; Upton C; McFadden G Virology; 1985 Jan; 140(1):113-24. PubMed ID: 2981446 [TBL] [Abstract][Full Text] [Related]
53. Abortive replication of vaccinia virus in activated rabbit macrophages. Buchmeier NA; Gee SR; Murphy FA; Rawls WE Infect Immun; 1979 Oct; 26(1):328-38. PubMed ID: 500210 [TBL] [Abstract][Full Text] [Related]
54. Demonstration of cytotoxic antibodies in rabbits bearing tumors induced by Shope fibroma virus. Singh SB; Smith JW; Rawls WE; Tevethia SS Infect Immun; 1972 Mar; 5(3):352-8. PubMed ID: 4344218 [TBL] [Abstract][Full Text] [Related]
55. In vitro and in vivo inhibition of myxoma virus by treatment with phosphonoacetic acid. Goodrich JM; Lee KW; Hinze HC Arch Virol; 1981; 70(2):157-64. PubMed ID: 7332492 [TBL] [Abstract][Full Text] [Related]
56. VIRUSES OF THE MYXOMA-FIBROMA SUBGROUP OF THE POXVIRUSES. I. PLAQUE PRODUCTION IN CULTURED CELLS, PLAQUE-REDUCTION TESTS, AND CROSS-PROTECTION TESTS IN RABBITS. WOODROOFE GM; FENNER F Aust J Exp Biol Med Sci; 1965 Apr; 43():123-42. PubMed ID: 14323551 [No Abstract] [Full Text] [Related]
57. DNA ligase gene disruptions can depress viral growth and replication in poxvirus-infected cells. Parks RJ; Winchcombe-Forhan C; DeLange AM; Xing X; Evans DH Virus Res; 1998 Aug; 56(2):135-47. PubMed ID: 9783462 [TBL] [Abstract][Full Text] [Related]
58. Reactivation of heat-inactivated poxviruses: a general phenomenon which includes the fibroma-myxoma virus transformation of Berry and Dedrick. FENNER F; HOLMES IH; JOKLIK WK; WOODROOFE GM Nature; 1959 May; 183(4671):1340-1. PubMed ID: 13657116 [No Abstract] [Full Text] [Related]
59. Swinepox. Virus isolation, experimental infections and the differentiation from vaccinia virus infections. De Boer GF Arch Virol; 1975; 49(2-3):141-50. PubMed ID: 174522 [TBL] [Abstract][Full Text] [Related]
60. Fluctuations in the titre of antibody to a soluble antigen of myxoma virus in field populations of rabbits, Oryctolagus cuniculus (L.), in Australia. Williams RT; Dunsmore JD; Sobey WR J Hyg (Lond); 1973 Sep; 71(3):487-500. PubMed ID: 4518348 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]